Interaction of the bioactive flavonol, icariin, with the essential human solute carrier transporters

Journal of Biochemical and Molecular Toxicology

Volumn 28, Issue 2, 2014, Pages 91-97

  Li, Zhen ^a   Cheung, Florence Shin Gee ^a   Zheng, Jian ^a,b   Chan, Ting ^a   Zhu, Ling ^c   Zhou, Fanfan ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NORTHEAST FORESTRY UNIVERSITY   (China)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Icariin; OATP1B3; OATP2B1; Solute carrier transporters

Indexed keywords

ICARIIN; OATP1B3; OATP2B1; SOLUTE CARRIER TRANSPORTERS;

FLAVONOIDS; HEK293 CELLS; HUMANS; KIDNEY; LIVER; ORGANIC ANION TRANSPORTERS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT;

EID: 84893787446     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21540     Document Type: Article

References (50)

1. Zhang L, Yan J, Liu X, Ye Z, Yang X, Meyboom R, Chan K, Shaw D, Duez P. Pharmacovigilance practice and risk control of traditional Chinese medicine drugs in China: Current status and future perspective. J Ethnopharmacol 2012;140(3):519-525.
2. Zuo F, Zhou Z-M, Liu M-L. Determination of 14 chemical constituents in the traditional Chinese medicinal preparation Huangqin-Tang by high performance liquid chromatography. Biol Pharm Bull 2001;24(6):693-697.
3. Liu HT, Wang KT, Zhang HY, Chen XG, Hu ZD. Electrophoretic behavior study and determination of some active components in Chinese medicinal preparations by capillary electrophoresis. Analyst 2000;125(6):1083-1086.
4. Wang Y, Dong H, Zhu M, Ou Y, Zhang J, Luo H, Luo R, Wu J, Mao M, Liu X, Zhang J, Wei L. Icariin exterts negative effects on human gastric cancer cell invasion and migration by vasodilator-stimulated phosphoprotein via Rac1 pathway. Eur J Pharmacol 2010;635(1-3):40-48.
5. Li Y, Duan J, Guo T, Xie W, Yan S, Li B, Zhou Y, Chen Y. In vivo pharmacokinetics comparisons of icariin, emodin and psoralen from Gan-kang granules and extracts of Herba Epimedii, Nepal dock root, Ficus hirta yahl. J Ethnopharmacol 2009;124(3):522-529.
6. Xie J, Sun W, Duan K, Zhang Y. Chemical constituents of roots of Epimedium wushanense and evaluation of their biological activities. Nat Prod Res 2007;21(7):600-605.
7. Zhao F, Tang Y-Z, Liu Z-Q. Protective effect of icariin on DNA against radical-induced oxidative damage. J Pharm Pharmacol 2007;59(12):1729-1732.
8. Pan Y, Kong L, Xia X, Zhang W, Xia Z, Jiang F. Antidepressant-like effect of icariin and its possible mechanism in mice. Pharmacol Biochem Behav 2005;82(4):686-694.
9. Pan Y, Zhang WY, Xia X, Kong LD. Effects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague-Dawley rats. Biol Pharm Bull 2006;29(12):2399-2403.
10. Pan Y, Kong LD, Li YC, Xia X, Kung HF, Jiang FX. Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. Pharmacol Biochem Behav 2007;87(1):130-140.
11. Luo Y, Nie J, Gong QH, Lu YF, Wu Q, Shi JS. Protective effects of icariin against learning and memory deficits induced by aluminium in rats. Clin Exp Pharmacol Physiol 2007;34(8):792-795.
12. Zheng M, Qu L, Lou Y. Effects of icariin combined with Panax notoginseng saponins on ischemia reperfusion-induced cognitive impairments related with oxidative stress and CA1 of hippocampal neurons in rat. Phytother Res 2008;22(5):597-604.
13. Li S, Dong P, Wang J, Zhang J, Gu J, Wu X, Wu W, Fei X, Zhang Z, Wang Y, Quan Z, Liu Y. Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway. Cancer Lett 2010;298(2):222-230.
14. Mao H.T, Zhang L, Wang Y, Li X.B. Modulation of expression of metastatic correlated genes in human highly metastatic lung tumor cell line by icariin and Pja. Tumor 2000;20:13-15.
15. Mao HT, Zhang L, Wang Y, Li XP, Cui ZY. Studies of suppression on invasion and metastasis ability of high metastatic human lung tumor cell line. Chin J Immunol 2001;17:27-35.
16. Cao YF, He RR, Cao J, Chen JX, Huang T, Liu Y. Drug-drug interactions potential of icariin and its intestinal metabolites via inhibition of intestinal UDP-glucuronosyltransferases. Evid-Based Complement Alternat Med 2012;2012:8.
17. Zhang Y, Wang QS, Cui YL, Meng FC, Lin KM. Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins. Int J Nanomedicine 2012;7:4239-49.
18. Wu YT, Lin CW, Lin LC, Chiu AW, Chen KK, Tsai TH. Analysis of biliary excretion of icariin in rats. J Agric Food Chem 2010;58(18):9905-9911.
19. Roth M, Obaidat A, Hagenbuch B. OATPs, OATs and OCTs: The organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Brit J Pharmacol 2012;165(5):1260-1287.
20. Zhou F, You G. Molecular insights into the structure-function relationship of organic anion transporters OATs. Pharm Res 2007;24(1):28-36.
21. Xu F, Li Z, Zheng J, Gee Cheung FS, Chan T, Zhu L, Zhuge H, Zhou F. The inhibitory effects of the bioactive components isolated from Scutellaria baicalensis on the cellular uptake mediated by the essential solute carrier transporters (SLCs). J Pharm Sci 2013.
22. Mandery K, Bujok K, Schmidt I, Keiser M, Siegmund W, Balk B, König J, Fromm MF, Glaeser H. Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochem Pharmacol 2010;80(11):1746-1753.
23. Wu LX, Guo CX, Qu Q, Yu J, Chen WQ, Wang G, Fan L, Li Q, Zhang W, Zhou HH. Effects of natural products on the function of human organic anion transporting polypeptide 1B1. Xenobiotica 2012;42(4):339-348.
24. Wang L, Sweet DH. Potential for food-drug interactions by dietary phenolic acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11). Biochem Pharmacol 2012;84(8):1088-1095.
25. Mandery K, Balk B, Bujok K, Schmidt I, Fromm MF, Glaeser H. Inhibition of hepatic uptake transporters by flavonoids. Eur J Pharm Sci 2012;46(1-2):79-85.
26. Zhou F, Zhu L, Cui PH, Church WB, Murray M. Functional characterization of nonsynonymous single nucleotide polymorphisms in the human organic anion transporter 4 (hOAT4). Br J Pharmacol 2010;159(2):419-427.
27. Race JE, Grassl SM, Williams WJ, Holtzman EJ. Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun 1999;255(2):508-514.
28. Ueo H, Motohashi H, Katsura T, Inui K. Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem Pharmacol 2005;70(7):1104-1113.
29. Ugele B, Bahn A, Rex-Haffner M. Functional differences in steroid sulfate uptake of organic anion transporter 4 (OAT4) and organic anion transporting polypeptide 2B1 (OATP2B1) in human placenta. J Steroid Biochem Mol Biol 2008;111(1-2):1-6.
30. Zhou F, Lee AC, Krafczyk K, Zhu L, Murray M. Protein kinase C regulates the internalization and function of the human organic anion transporting polypeptide 1A2. Br J Pharmacol 2011;162(6):1380-1388.
31. Noé J, Portmann R, Brun ME, Funk C. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3. Drug Metab Dispos 2007;35(8):1308-1314.
32. Hirano M, Maeda K, Shitara Y, Sugiyama Y. Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans. J Pharmacol Exp Ther 2004;311(1):139-146.
33. Amphoux A, Millan MJ, Cordi A, Bönisch H, Vialou V, Mannoury la Cour C, Dupuis DS, Giros B, Gautron S. Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: A comparison to human α1- and α2-adrenoceptor subtypes. Eur J Pharm 2010;634(1-3):1-9.
34. Gründemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, Schömig E. Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA 2005;102(14):5256-5261.
35. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 1998;273(32):20378-20382.
36. Toh DS, Murray M, Pern Tan K, Mulay V, Grewal T, Lee EJ, Zhou F. Functional analysis of pharmacogenetic variants of human organic cation/carnitine transporter 2 (hOCTN2) identified in Singaporean populations. Biochem Pharmacol 2011;82(11):1692-1699.
37. Ahlin G, Hilgendorf C, Karlsson J, Szigyarto CA, Uhlén M, Artursson P. Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs. Drug Metab Dispos 2009;37(12):2275-2283.
38. Zhou F, Illsley NP, You G. Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells. Eur J Pharm Sci 2006;27(5):518-523.
39. Zhou F, Zheng J, Zhu L, Jodal A, Cui PH, Wong M, Gurney H, Church WB, Murray M. Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2. AAPS J 2013;15(4):1099-1108.
40. Toh DSL, et al. Functional analysis of novel variants in the organic cation/ergothioneine transporter 1 identified in Singapore populations. Mol Pharm 2013;10(7):2509-2516.
41. Ho CK, Tan H. Rise of herbal and traditional medicine in erectile dysfunction management. Curr Urol Rep 2011;12(6):470-478.
42. Zhou J, Wu J, Chen X, Fortenbery N, Eksioglu E, Kodumudi KN, Pk EB, Dong J, Djeu JY, Wei S. Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. Int Immunopharmacol 2011;11(7):890-898.
43. König J, Cui Y, Nies AT, Keppler D. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem 2000;275(30):23161-23168.
44. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 2001;120(2):525-533.
45. Glaeser H, Bailey DG, Dresser GK, Gregor JC, Schwarz UI, McGrath JS, Jolicoeur E, Lee W, Leake BF, Tirona RG, Kim RB. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin Pharmacol Ther 2007;81(3):362-370.
46. Sai Y, Kaneko Y, Ito S, Mitsuoka K, Kato Y, Tamai I, Artursson P, Tsuji A. Predominant contribution of organic anion transporting polypeptide oatp-b (oatp2b1) to apical uptake of estrone-3-sulfate by human intestinal caco-2 cells. Drug Metab Dispos 2006;34(8):1423-1431.
47. Shirasaka Y, Suzuki K, Nakanishi T, Tamai I. Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide. Pharm Res 2010;27(10):2141-2149.
48. Liu J, Lou Y-j. Determination of icariin and metabolites in rat serum by capillary zone electrophoresis: rat pharmacokinetic studies after administration of icariin. J Pharm Biomed Anal 2004;36(2):365-370.
49. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP. Structure-based identification of OATP1B1/3 inhibitors. Mol Pharmacol 2013.
50. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P. Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): Influence of protein expression on drug-drug interactions. J Med Chem 2012;55(10):4740-4763.